PAL-AHK (Palmitoyl Tripeptide-1)

Quick Facts

Introduction

PAL-AHK, also known as palmitoyl tripeptide-1, is a synthetic cosmetic peptide built from the tripeptide Ala-His-Lys (AHK) with a palmitic-acid (palmitoyl) chain attached at the N-terminus. It belongs to the family of matrikine-derived signal peptides — short sequences that resemble fragments of extracellular-matrix proteins and that cells interpret as instructions to remodel the matrix. Within the skin-and-hair research category it is studied alongside GHK-Cu and SNAP-8.

The conceptual logic of PAL-AHK research is twofold. First, the AHK sequence is studied as a messenger that signals dermal fibroblasts to increase production of collagen and other matrix components. Second, the palmitoyl lipid chain is added to address a practical problem common to cosmetic peptides — poor penetration of the skin's lipid barrier — by making the molecule amphiphilic and more compatible with the stratum corneum.

This profile covers what PAL-AHK is, its lipidated-matrikine structure, the matrix-signaling mechanism it is studied for, and how it compares with related cosmetic peptides catalogued in the peptide database. It is framed as topical cosmetic-science research.

What is PAL-AHK?

PAL-AHK is a palmitoylated tripeptide: the three amino acids alanine, histidine, and lysine joined to a 16-carbon palmitic-acid chain. The AHK core is a matrikine-type sequence studied for its signaling activity, while the palmitoyl group is a lipid modification borrowed from the broader class of cosmetic 'palmitoyl peptides' that includes Matrixyl (palmitoyl pentapeptide-4).

Like other matrikine peptides, PAL-AHK is used almost entirely in topical cosmetic-science research at low formulation concentrations. The histidine and lysine residues also give the AHK motif an affinity for copper, which links it conceptually to copper-peptide chemistry, though PAL-AHK is most often studied as a standalone signal peptide rather than as a copper carrier in the way GHK-Cu is.

Molecular and structural characteristics

Structurally, PAL-AHK is amphiphilic: a short hydrophilic peptide head (AHK) joined to a long hydrophobic palmitoyl tail. This dual character is the defining feature studied in the literature, because the lipid tail is what allows the otherwise water-loving peptide to associate with and traverse the lipid-rich stratum corneum. The histidine imidazole and lysine amine in the head retain the matrikine signaling character of the AHK motif.

Mechanism of action

PAL-AHK's studied mechanism is that of a matrikine — a peptide that mimics a fragment of an extracellular-matrix protein and is recognized by cells as a signal to rebuild that matrix. In cultured dermal-fibroblast models, the AHK motif is associated with up-regulated synthesis of collagen and other matrix components, which researchers interpret as a messenger-peptide effect rather than a structural or enzymatic one.

The palmitoyl chain plays a mechanistic role of its own: by improving partitioning into the lipid barrier, it is studied as a means of delivering the AHK signal to the viable epidermis and dermis where fibroblasts reside. In this sense PAL-AHK's action is the combination of a signaling head and a delivery tail, and cosmetic-science studies treat both as essential to the observed activity.

Because matrikine signaling targets the structural matrix, PAL-AHK's mechanism is complementary to the neuromuscular modulation studied for SNAP-8 and overlaps conceptually with the matrix-remodeling actions of GHK-Cu. This is why the three are frequently catalogued and studied together within skin research.

• Acts as a matrikine signal mimicking a matrix-protein fragment.
• Associated with stimulation of collagen and matrix synthesis by fibroblasts.
• Palmitoyl chain studied for improved penetration of the lipid barrier.
• Targets the structural matrix rather than neuromuscular signaling.

Collagen and matrix research applications

The dominant research context for PAL-AHK is dermal matrix support in cosmetic science. Fibroblast-culture studies have associated the AHK motif with increased collagen output, and formulation studies examine whether topical products containing palmitoyl tripeptide-1 are associated with measurable changes in skin firmness, elasticity, or fine-line appearance over weeks of application in study populations.

Researchers frame PAL-AHK within the broader palmitoyl-peptide strategy that also produced Matrixyl (palmitoyl pentapeptide-4): take a short signaling sequence and lipidate it to overcome skin-penetration limits. The recurring interpretive question is how much of the observed benefit reflects the AHK signal itself versus the improved delivery conferred by the lipid chain.

Hair and delivery-focused research

PAL-AHK is also studied in the context of hair and scalp cosmetic research, where the AHK-copper affinity and matrix-signaling theme overlap with interest in follicle and perifollicular tissue. As with the skin work, these applications are framed around messenger-peptide signaling and the matrix environment rather than a direct, receptor-specific growth pathway.

A distinct research thread concerns the delivery science of lipidated peptides generally. Because palmitoylation is a widely used tactic, PAL-AHK serves as one model for studying how lipid-chain length and formulation affect peptide penetration and stability, lessons that inform the design of other cosmetic peptides.

Comparison: PAL-AHK vs GHK-Cu vs SNAP-8

PAL-AHK is most often compared with GHK-Cu, a copper-binding tripeptide, and SNAP-8, a neurotransmitter-release modulator. All three are skin-research peptides, but their mechanisms are largely non-overlapping, which is precisely why they are studied together.

Researchers sometimes combine structural and copper peptides — for instance PAL-AHK with GHK-Cu — to study complementary matrix mechanisms. Full entries for each are in the peptide database.

Half-life and pharmacokinetic considerations

Because PAL-AHK is studied as a topical agent, conventional systemic pharmacokinetics are of secondary relevance; the central question is local penetration and retention within the skin. The palmitoyl chain is studied precisely because it improves how the peptide partitions into and persists within the lipid barrier, changing local exposure more than it changes any circulating half-life.

As an amphiphilic molecule, PAL-AHK's behavior is strongly formulation-dependent: the choice of emulsion, solvent, and concentration governs how the signaling head is delivered to fibroblasts. This makes delivery vehicle a primary interpretive variable in PAL-AHK research, more so than half-life figures.

Reconstitution and handling considerations

Unlike fully water-soluble peptides, PAL-AHK's palmitoyl chain makes it amphiphilic, so it is often handled in solvent or formulation systems suited to lipidated peptides rather than plain water. Where an aqueous working stock is prepared, diluent is added slowly and the vial swirled gently rather than shaken, and the solution is inspected for clarity or appropriate dispersion.

Working concentrations are selected so research volumes are convenient and reproducible. The reconstitution calculator and reconstitution guide describe the general method, with the caveat that lipidated peptides may require co-solvents.

• Account for the amphiphilic palmitoyl chain when selecting a diluent or co-solvent.
• Add diluent slowly; swirl gently rather than shaking.
• Confirm clarity or appropriate dispersion before use.
• Protect from light and excess warmth; avoid repeated freeze–thaw cycles.

Storage considerations

Lyophilized PAL-AHK is most stable frozen at −20 °C, kept dry and away from light. Once reconstituted or dispersed, it is refrigerated at 2–8 °C and used within a limited window; aliquoting reduces how often a given solution is cycled.

Research limitations

PAL-AHK is a research compound whose evidence comes largely from in-vitro fibroblast studies and cosmetic-science formulation work, often manufacturer-sponsored, rather than large independent trials. Disentangling the contribution of the AHK signal from that of the palmitoyl delivery chain, and the strong formulation dependence of results, both limit interpretation. It is described here strictly for research reference.

• Most data come from in-vitro and cosmetic-science formulation studies.
• Benefit is hard to separate between AHK signaling and palmitoyl delivery.
• Reported effects are concentration- and formulation-dependent.
• It is not an approved therapy and is described solely for research reference.

Frequently Asked Questions

Related Research Profiles

References

1. Schagen SK. Topical Peptide Treatments with Effective Anti-Aging Results. Cosmetics. 2017.Source
2. Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci. 2009.Source